Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesTwo-Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS EXPRESS Stents and Bypass Surger
Boston Scientific, 09/03/09
Boston Scientific Corporation announced two–year data from its SYNTAX clinical trial comparing percutaneous coronary intervention using the TAXUS Express Paclitaxel–Eluting Coronary Stent System to coronary artery bypass graft surgery. The overall results demonstrated no statistically significant difference between PCI and CABG in the composite safety endpoint. The Company made the announcement at the annual European Society of Cardiology (ESC) Congress in Barcelona.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children – a double-blind randomized study
Alimentary Pharmacology and Therapeutics, 12/04/09
The Unintended Consequences of Clinical Trials Regulations
PLoS Medicine, 12/04/09
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials
BMC Infectious Diseases, 12/03/09
Sponsor
Article Search
Sponsor